Delivery Order SPE2DE23D0008-SPE2D626F05BK
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order on November 18, 2025, for Natrelle Inspira SSM 255CC breast implants. This delivery order, issued without set-aside designation, is scheduled for completion by December 3, 2025, and represents a child contract under one of Allergan's two significant Indefinite Delivery/Indefinite Quantity contracts with the Defense Logistics Agency Troop Support Medical. The $13.5 million IDV for Natrelle breast...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,814 delivery order for Natrelle Inspira SCF 485CC breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment was awarded on December 9, 2025, with an ultimate completion date of December 11, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as the sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order on December 29, 2025, for Natrelle Inspira SCX 615CC breast implants, with performance completion targeted for December 31, 2025. The contract was awarded without set-aside designation and represents a child order under Allergan's larger Indefinite Delivery Vehicle agreements with the Defense Logistics Agency Troop Support Medical. Performance will occur at the contractor's facility in Irvine,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, for Natrelle Inspira SCX 750cc breast implants. The contract, which carries no set-aside designation, is classified as a child order under a larger Indefinite Delivery Vehicle and reflects Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The delivery order is set to...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F05BKDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order on January 2, 2026, for Natrelle Inspira SSM 255cc breast implants, with a completion date of January 15, 2026. The contract was issued without set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency. Performance will take place in Irvine, California. This delivery order represents a task order issued under one of Allergan's larger Indefinite Delivery Vehicle contracts with DLA Troop Support Medical, specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established in December 2022. The award supports reconstructive and aesthetic surgical procedures conducted at military treatment facilities, Department of Defense hospitals, and clinics. Allergan maintains a sole-source position as the primary supplier of Natrelle-branded breast implants to federal healthcare systems, with all recent awards structured as fixed-price contracts with economic price adjustment provisions. The company's federal contracting activity reflects its critical role in providing specialized medical devices to support the healthcare needs of military members, veterans, and other populations served by the Department of Defense medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/1/26 |